» Authors » Anne Waldo

Anne Waldo

Explore the profile of Anne Waldo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekula N, Plowden T, Waldo A, Bryce R, Castillo-Mackenzie M, Acosta S, et al.
J Clin Transl Sci . 2022 May; 6(1):e40. PMID: 35574152
Background: Although one of the fastest-growing populations in the USA, Latinx individuals remain underrepresented in research. In this study, we aimed to identify how Latina/Latinx participants of the Environment, Leiomyomas,...
2.
Bernardi L, Waldo A, Berrocal V, Wise L, Marsh E
Fertil Steril . 2022 Feb; 117(4):832-840. PMID: 35105447
Objective: To evaluate the extent to which uterine fibroids are associated with antimüllerian hormone (AMH) concentrations. Design: Cross-sectional study. Setting: Baseline data from the Study of the Environment, Lifestyle, and...
3.
Bernardi L, Weiss M, Waldo A, Harmon Q, Carnethon M, Baird D, et al.
Fertil Steril . 2021 Mar; 116(1):208-217. PMID: 33752880
Objective: To assess whether the duration, recency, or type of hormonal contraceptive used is associated with antimüllerian hormone (AMH) levels, given that the existing literature regarding the association between hormonal...
4.
Modi Z, Waldo A, Selewski D, Troost J, Gipson D
Am J Kidney Dis . 2020 Oct; 77(4):500-508. PMID: 33058964
Rationale & Objective: The impact of chronic kidney disease (CKD) on inpatient health care use is unknown. This study aimed to describe the prevalence of pediatric CKD among children hospitalized...
5.
Troost J, Waldo A, Carlozzi N, Murphy S, Modersitzki F, Trachtman H, et al.
Clin Kidney J . 2020 Sep; 13(4):597-606. PMID: 32905199
Background: Understanding the relationship between clinical and patient-reported outcomes (PROs) will help support clinical care and future clinical trial design of novel therapies for focal segmental glomerulosclerosis (FSGS). Methods: FSGS...
6.
Weaver Jr D, Waldo A, Oh G, Kamil E, Elliott M, Adler S, et al.
Kidney Med . 2020 Aug; 2(2):131-138. PMID: 32734234
Rationale & Objective: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. Study Design: Retrospective...
7.
Gipson D, Trachtman H, Waldo A, Gibson K, Eddy S, Dell K, et al.
Kidney Int Rep . 2020 Apr; 5(4):414-425. PMID: 32280839
Introduction: Childhood-onset nephrotic syndrome has a variable clinical course. Improved predictive markers of long-term outcomes in children with nephrotic syndrome are needed. This study tests the association between baseline urinary...
8.
Oh G, Waldo A, Paez-Cruz F, Gipson P, Pesenson A, Selewski D, et al.
Kidney Int Rep . 2020 Jan; 4(11):1608-1616. PMID: 31891002
Introduction: The goal of this study was to assess the occurrence of steroid-associated adverse events (SAAE) in patients with primary proteinuric kidney disease. Methods: The Kidney Research Network Registry consists...
9.
Gipson D, Selewski D, Massengill S, Modes M, Desmond H, Lee L, et al.
Kidney Int Rep . 2018 May; 3(2):439-446. PMID: 29725648
Introduction: NephCure Accelerating Cures Institute (NACI) is a collaborative organization sponsored by NephCure Kidney International and the University of Michigan. The Institute is composed of 7 cores designed to improve...